Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.
Ronceray L, Dworzak M, Dieckmann K, Ebetsberger-Dachs G, Glogova E, Haas OA, Jones N, Nebral K, Moser R, Lion T, Meister B, Panzer-Grümayer R, Strehl S, Peters C, Pötschger U, Urban C, Mann G, Attarbaschi A; Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Ronceray L, et al. Among authors: meister b. Wien Klin Wochenschr. 2023 Aug 3. doi: 10.1007/s00508-023-02249-6. Online ahead of print. Wien Klin Wochenschr. 2023. PMID: 37535134
Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study.
Modritz D, Ladenstein R, Pötschger U, Amman G, Dieckmann K, Horcher E, Urban C, Meister B, Schmitt K, Jones R, Kaulfersch W, Haas H, Moser R, Stöllinger O, Peham M, Gadner H, Koscielniak E, Treuner J. Modritz D, et al. Among authors: meister b. Wien Klin Wochenschr. 2005 Mar;117(5-6):196-209. doi: 10.1007/s00508-004-5-0285-8. Wien Klin Wochenschr. 2005. PMID: 15875759 Clinical Trial.
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Reismüller B, Attarbaschi A, Peters C, Dworzak MN, Pötschger U, Urban C, Fink FM, Meister B, Schmitt K, Dieckmann K, Henze G, Haas OA, Gadner H, Mann G; Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Reismüller B, et al. Among authors: meister b. Br J Haematol. 2009 Feb;144(4):559-70. doi: 10.1111/j.1365-2141.2008.07499.x. Epub 2008 Dec 5. Br J Haematol. 2009. PMID: 19077160 Free article.
Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.
Prucker C, Attarbaschi A, Peters C, Dworzak MN, Pötschger U, Urban C, Fink FM, Meister B, Schmitt K, Haas OA, Gadner H, Mann G; Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Prucker C, et al. Among authors: meister b. Leukemia. 2009 Jul;23(7):1264-9. doi: 10.1038/leu.2009.12. Epub 2009 Feb 12. Leukemia. 2009. PMID: 19212332
The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Pichler H, Reismüller B, Steiner M, Dworzak MN, Pötschger U, Urban C, Meister B, Schmitt K, Panzer-Grümayer R, Haas OA, Attarbaschi A, Mann G; Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Pichler H, et al. Among authors: meister b. Br J Haematol. 2013 May;161(4):556-65. doi: 10.1111/bjh.12292. Epub 2013 Mar 11. Br J Haematol. 2013. PMID: 23480776 Free article.
Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group.
Reismüller B, Peters C, Dworzak MN, Pötschger U, Urban C, Meister B, Schmitt K, Dieckmann K, Gadner H, Attarbaschi A, Mann G; Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Reismüller B, et al. Among authors: meister b. J Pediatr Hematol Oncol. 2013 Jul;35(5):e200-4. doi: 10.1097/MPH.0b013e318290c3d6. J Pediatr Hematol Oncol. 2013. PMID: 23652878
High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Reismüller B, Steiner M, Pichler H, Dworzak M, Urban C, Meister B, Schmitt K, Pötschger U, König M, Mann G, Haas OA, Attarbaschi A; Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Reismüller B, et al. Among authors: meister b. Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26327. Epub 2016 Nov 2. Pediatr Blood Cancer. 2017. PMID: 27804199 Clinical Trial.
Development of treatment and clinical results in childhood AML in Austria (1993-2013).
Boztug H, Mühlegger N, Glogova E, Mann G, Urban C, Meister B, Schmitt K, Jones N, Attarbaschi A, Haas O, Strehl S, Lion T, Pötschger U, Fink FM, Gadner H, Dworzak M. Boztug H, et al. Among authors: meister b. Memo. 2014;7(1):63-74. doi: 10.1007/s12254-014-0135-y. Epub 2014 Mar 1. Memo. 2014. PMID: 32288851 Free PMC article.
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Fiedler S, Ambros IM, Glogova E, Benesch M, Urban C, Mayer M, Ebetsberger-Dachs G, Bardi E, Jones N, Gamper A, Meister B, Crazzolara R, Amann G, Dieckmann K, Horcher E, Kerbl R, Brunner-Herglotz B, Ziegler A, Ambros PF, Ladenstein R. Fiedler S, et al. Among authors: meister b. Cancers (Basel). 2021 Feb 2;13(3):572. doi: 10.3390/cancers13030572. Cancers (Basel). 2021. PMID: 33540616 Free PMC article.
Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and flow cytometric immunophenotyping.
Mann G, Attarbaschi A, Steiner M, Simonitsch I, Strobl H, Urban C, Meister B, Haas O, Dworzak M, Gadner H; Austrian Berlin-Frankfurt-Münster (BFM) Group. Mann G, et al. Among authors: meister b. Pediatr Hematol Oncol. 2006 Apr-May;23(3):167-76. doi: 10.1080/08880010500506354. Pediatr Hematol Oncol. 2006. PMID: 16526117
269 results